Viewing Study NCT00101595


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2026-01-26 @ 11:01 AM
Study NCT ID: NCT00101595
Status: COMPLETED
Last Update Posted: 2011-04-14
First Post: 2005-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor:
Organization: